Group One Trading’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Group One Trading’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-25,845	Closed	-$2.99M	–	8521
2023 Q3	$2.99M	Buy	+25,845	New	+$2.78M	0.01%	1313
2023 Q2	–	Sell	-21,795	Closed	-$2.3M	–	8522
2023 Q1	$2.38M	Buy	+21,795	New	+$2.41M	0.01%	1388
2022 Q4	–	Sell	-12,251	Closed	-$1.02M	–	8550
2022 Q3	$758K	Buy	12,251 +7,378	+151%	+$516K	﹤0.01%	2846
2022 Q2	$389K	Buy	+4,873	New	+$461K	﹤0.01%	3656
2022 Q1	–	Sell	-6,193	Closed	-$604K	–	9195
2021 Q4	$667K	Sell	6,193 -12,971	-68%	-$1.41M	﹤0.01%	3796
2021 Q3	$2.1M	Buy	+19,164	New	+$1.99M	﹤0.01%	2601
2021 Q2	–	Sell	-110,139	Closed	-$10.1M	–	8901
2021 Q1	$10.1M	Buy	110,139 +6,065	+6%	+$512K	0.02%	934
2020 Q4	$7.61M	Buy	104,074 +92,947	+835%	+$6.91M	0.01%	988
2020 Q3	$864K	Buy	+11,127	New	+$766K	﹤0.01%	2334
2020 Q1	–	Sell	-159,071	Closed	-$5.38M	–	6140
2019 Q4	$5.76M	Buy	+159,071	New	+$4.88M	0.04%	598
2019 Q2	–	Sell	-31,132	Closed	-$790K	–	5735
2019 Q1	$823K	Buy	+31,132	New	+$738K	0.01%	1550
2018 Q3	–	Sell	-90,566	Closed	-$1.72M	–	5897
2018 Q2	$1.5M	Sell	90,566 -1,303	-1%	-$19.9K	0.01%	1336
2018 Q1	$1.3M	Buy	91,869 +23,529	+34%	+$348K	0.01%	1308
2017 Q4	$998K	Buy	68,340 +42,439	+164%	+$596K	0.01%	1699
2017 Q3	$328K	Sell	25,901 -18,966	-42%	-$241K	﹤0.01%	2395
2017 Q2	$533K	Sell	44,867 -22,396	-33%	-$279K	0.01%	1928
2017 Q1	$994K	Sell	67,263 -162,021	-71%	-$2.62M	0.01%	1340
2016 Q4	$3.71M	Sell	229,284 -48,246	-17%	-$875K	0.04%	559
2016 Q3	$5.03M	Buy	277,530 +114,674	+70%	+$2.24M	0.05%	410
2016 Q2	$2.68M	Buy	162,856 +36,927	+29%	+$597K	0.03%	656
2016 Q1	$2.09M	Buy	125,929 +33,578	+36%	+$588K	0.03%	746
2015 Q4	$2M	Buy	92,351 +3,062	+3%	+$59.6K	0.02%	852
2015 Q3	$1.77M	Sell	89,289 -30,017	-25%	-$948K	0.02%	865
2015 Q2	$4.14M	Buy	119,306 +53,736	+82%	+$1.64M	0.06%	396
2015 Q1	$1.7M	Buy	+65,570	New	+$1.2M	0.03%	729
2014 Q4	–	Sell	-62,938	Closed	-$788K	–	5499
2014 Q3	$772K	Buy	+62,938	New	+$731K	0.01%	1283
2014 Q1	–	Sell	-927	Closed	-$10.5K	–	5782
2013 Q4	$7K	Sell	927 -6,107	-87%	-$32.9K	﹤0.01%	4758
2013 Q3	$24K	Sell	7,034 -30,310	-81%	-$79.9K	﹤0.01%	4071
2013 Q2	$92K	Buy	+37,344	New	+$89.6K	﹤0.01%	2904

Other funds holding HZNP

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Group One Trading's HZNP Position: Q4 2023 in Review

Group One Trading sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 25,845 shares — an estimated $2.99M sold.

Group One Trading first reported a position in HZNP in Q2 2013 and held it in 29 quarters. The position peaked at $10.1M in Q1 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Group One Trading reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Group One Trading sold 25,845 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $2.99M.
Group One Trading first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2013 and held it in 29 quarters.
Group One Trading's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $10.1M in Q1 2021.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Group One Trading's 13F filing for Q4 2023, filed 14 Feb 2024.